AI assistant
Amalgamated Financial Corp. — Director's Dealing 2025
Nov 4, 2025
32385_dirs_2025-11-03_890a565f-703b-41ac-92b1-6c0a3da48e99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amalgamated Financial Corp. (AMAL)
CIK: 0001823608
Period of Report: 2025-10-30
Reporting Person: Kelly Julie (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-30 | Common Stock | M | 4820 | $12 | Acquired | 21590 | Direct |
| 2025-10-30 | Common Stock | F | 2340 | $27.5575 | Disposed | 19250 | Direct |
| 2025-10-30 | Common Stock | M | 4220 | $13.75 | Acquired | 23470 | Direct |
| 2025-10-30 | Common Stock | F | 2048 | $27.5575 | Disposed | 21422 | Direct |
| 2025-10-30 | Common Stock | M | 3960 | $14.65 | Acquired | 25382 | Direct |
| 2025-10-30 | Common Stock | F | 1922 | $27.5575 | Disposed | 23460 | Direct |
| 2025-10-31 | Common Stock | S | 6697 | $27.3416 | Disposed | 16763 | Direct |
| 2025-11-01 | Common Stock | A | 2311 | — | Acquired | 19074 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-30 | Non-Qualified Stock Option (right to buy) | $12 | M | 4820 | Disposed | 2026-01-01 | Common Stock (4820) | Direct |
| 2025-10-30 | Non-Qualified Stock Option (right to buy) | $13.75 | M | 4220 | Disposed | 2027-01-01 | Common Stock (4220) | Direct |
| 2025-10-30 | Non-Qualified Stock Option (right to buy) | $14.65 | M | 3960 | Disposed | 2028-01-01 | Common Stock (3960) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.635 . The reporting person undertakes to provide to
AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range
set forth in footnote (1) to this Form 4.
F2: The reported transaction involved the reporting person's receipt of a grant of 2,311 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's
termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.